📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
In 2024, CompuGroup Medical SE & Co completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
CompuGroup Medical SE & Co has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CompuGroup Medical SE & Co’s data sources below and access millions more through our Disclosure Search.
In 2024, the total operational greenhouse gas (GHG) emissions ofCompuGroup Medical SE & Co amounted to18,391.27metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
In 2024, the total Scope 1 emissions of CompuGroup Medical SE & Co were 12,751.08 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
In 2024, CompuGroup Medical SE & Co reported Scope 2 greenhouse gas (GHG) emissions of 11,647.62 tCOâ‚‚e using the market-based method and 5,640.19 tCOâ‚‚e using the location-based method.a
In 2024, CompuGroup Medical SE & Co reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2024, CompuGroup Medical SE & Co reported 289,311.45 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of CompuGroup Medical SE & Co includes a breakdown across 8of the 15 Scope 3 categories defined by the GHG Protocol,up from 0 in , reflecting improved emissions accounting practices and greater transparency across the company's value chaina
In 2024, CompuGroup Medical SE & Co reported total Scope 3 emissions of 289,311.45 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 21.28%of these emissions originated from upstream activities such as purchased goods and capital goods, while 78.72%came from downstream activities like product use, distribution, and end-of-life treatment.a
In 2024, CompuGroup Medical SE & Co reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2024, the largest contributors to CompuGroup Medical SE & Co's Scope 3 emissions were:a
In 2024, CompuGroup Medical SE & Co reported a total carbon footprint of 307,702.72 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions.a
The largest contributor to CompuGroup Medical SE & Co's total carbon footprint was Scope 3 emissions, accounting for 94.02% of the company's total carbon footprint, followed by Scope 1 emissions at 4.14%.a